Zobrazeno 1 - 10
of 122
pro vyhledávání: '"Cristian Lolli"'
Autor:
Chiara Casadei, Emanuela Scarpi, Vincenza Conteduca, Giorgia Gurioli, Maria Concetta Cursano, Nicole Brighi, Cristian Lolli, Giuseppe Schepisi, Umberto Basso, Giuseppe Fornarini, Sara Bleve, Alberto Farolfi, Amelia Altavilla, Salvatore Luca Burgio, Emilio Francesco Giunta, Caterina Gianni, Alessia Filograna, Paola Ulivi, David Olmos, Elena Castro, Ugo De Giorgi
Publikováno v:
European Urology Open Science, Vol 61, Iss , Pp 44-51 (2024)
Background: The prevalence of pathogenic germline mutations in DNA damage repair (gDDR) genes in the Italian population is unknown. Objective: In this prospective multicenter cohort study, we evaluated the prevalence of gDDR alterations in the Italia
Externí odkaz:
https://doaj.org/article/da61ee9b940b4381ac3aa92030e5b551
Autor:
Cristian Lolli, Antonio Verde, Luca Degli Esposti, Valentina Acciai, Alessia Brigido, Emanuela Proietti, Sarah Scagliarini
Publikováno v:
Global & Regional Health Technology Assessment, Vol 11, Iss 1 (2024)
Background: Cabozantinib use in everyday clinical practice for advanced or metastatic renal cell carcinoma (RCC) is relatively recent, and real-world data on treatment persistence, adherence and sequencing are still limited. Methods: We conducted an
Externí odkaz:
https://doaj.org/article/865fa36da71b4714ab07b497d096df32
Autor:
Alberto Farolfi, Elisabetta Petracci, Giorgia Gurioli, Gianluca Tedaldi, Claudia Casanova, Valentina Arcangeli, Andrea Amadori, Marta Rosati, Marco Stefanetti, Salvatore Luca Burgio, Maria Concetta Cursano, Cristian Lolli, Valentina Zampiga, Ilaria Cangini, Giuseppe Schepisi, Ugo De Giorgi
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionPrimary debulking surgery (PDS), interval debulking surgery (IDS), and platinum-based chemotherapy are the current standard treatments for advanced ovarian cancer (OC). The time to initiation of adjuvant chemotherapy (TTC) could influence
Externí odkaz:
https://doaj.org/article/81e7da35c11248dd81c0be1df7cd92e2
Autor:
Vincenza Conteduca, Emanuela Scarpi, Paola Caroli, Cristian Lolli, Giorgia Gurioli, Nicole Brighi, Giulia Poti, Alberto Farolfi, Amelia Altavilla, Giuseppe Schepisi, Federica Matteucci, Giovanni Paganelli, Ugo De Giorgi
Publikováno v:
Molecular Oncology, Vol 16, Iss 2, Pp 538-548 (2022)
Plasma tumour DNA (ptDNA) is a potential early noninvasive biomarker of treatment outcome in metastatic castration‐resistant prostate cancer (mCRPC). Herein, we investigated whether pretreatment ptDNA levels reflect metabolic tumour burden in mCRPC
Externí odkaz:
https://doaj.org/article/5d48a31c73474ecbbe4e84ec246466a7
Autor:
Giorgia Gurioli, Vincenza Conteduca, Nicole Brighi, Emanuela Scarpi, Umberto Basso, Giuseppe Fornarini, Alessandra Mosca, Maurizio Nicodemo, Giuseppe Luigi Banna, Cristian Lolli, Giuseppe Schepisi, Giorgia Ravaglia, Isabella Bondi, Paola Ulivi, Ugo De Giorgi
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-13 (2022)
Abstract Background Cabazitaxel improves overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients progressing after docetaxel. In this prospective study, we evaluated the prognostic role of CTC gene expression on caba
Externí odkaz:
https://doaj.org/article/d29eb01c551a427fb416b8fbeaed9d19
Autor:
Giuseppe Schepisi, Caterina Gianni, Maria Concetta Cursano, Valentina Gallà, Cecilia Menna, Chiara Casadei, Sara Bleve, Cristian Lolli, Giovanni Martinelli, Giovanni Rosti, Ugo De Giorgi
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Germ cell tumors (GCTs) represent a heterogeneous neoplasm family affecting gonads and rarely occurring in extragonadal areas. Most of patients have a good prognosis, often even in the presence of metastatic disease; however, in almost 15% of cases,
Externí odkaz:
https://doaj.org/article/c50eee51ed964556a02d6720cb0123bb
Autor:
Jenny Bulgarelli, Claudia Piccinini, Elisabetta Petracci, Elena Pancisi, Anna Maria Granato, Francesco de Rosa, Massimo Guidoboni, Massimiliano Petrini, Valentina Ancarani, Giovanni Foschi, Antonino Romeo, Luca Tontini, Ugo De Giorgi, Cristian Lolli, Giorgia Gentili, Linda Valmorri, Alice Rossi, Fabio Ferroni, Carla Casadei, Pietro Cortesi, Laura Crudi, Laura Ridolfi
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
High-dose interleukin-2 (HD IL-2) has curative potential in metastatic melanoma (MM) and renal cell carcinoma (RCC). Radiotherapy (RT) kills cancer cells and induces immunomodulatory effects. Prospective trials exploring clinical and immunological pr
Externí odkaz:
https://doaj.org/article/a1699934b568420ab4dbf3699d2ce827
Autor:
Vincenza Conteduca, Emanuela Scarpi, Alberto Farolfi, Nicole Brighi, Lorena Rossi, Giorgia Gurioli, Cristian Lolli, Giuseppe Schepisi, Sara Bleve, Caterina Gianni, Alessandra Virga, Amelia Altavilla, Salvatore Luca Burgio, Cecilia Menna, Ugo De Giorgi
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
IntroductionMelphalan, as a bifunctional alkylating agent has been shown to be selectively efficient in BRCA-deficient case reports of epithelial ovarian cancer (EOC). The clinical benefit of melphalan on unselected platinum-resistant EOC population
Externí odkaz:
https://doaj.org/article/0d813f666bc6489d8c6434d5622e0e9c
Autor:
Giuseppe Schepisi, Maria Concetta Cursano, Chiara Casadei, Cecilia Menna, Amelia Altavilla, Cristian Lolli, Claudio Cerchione, Giovanni Paganelli, Daniele Santini, Giuseppe Tonini, Giovanni Martinelli, Ugo De Giorgi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-11 (2019)
Abstract Prostate cancer (PCa) is one of the main causes of cancer-related death in men. In the present immunotherapy era, several immunotherapeutic agents have been evaluated in PCa with poor results, possibly due to its low mutational burden. The r
Externí odkaz:
https://doaj.org/article/382e39b0c7b64284b9a272daa75e320e
Autor:
Vincenza Conteduca, Giorgia Gurioli, Lorena Rossi, Emanuela Scarpi, Cristian Lolli, Giuseppe Schepisi, Alberto Farolfi, Delia De Lisi, Valentina Gallà, Salvatore Luca Burgio, Cecilia Menna, Andrea Amadori, Lorena Losi, Dino Amadori, Maria Paola Costi, Ugo De Giorgi
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background The purpose of this study was to evaluate the clinical impact of oxaliplatin, leucovorin, and 5-fluorouracil (FOLFOX-4) chemotherapy in terms of the response rate, progression-free/overall survival (PFS/OS) and safety profile in p
Externí odkaz:
https://doaj.org/article/c7bf734d511e401a9cedd3755dfa4a9a